Omnicell

OMCL Small Cap

Healthcare · Health Information Services

Updated: Apr 5, 2026, 17:43 UTC

$34.15

+0.62% today

52W: $22.66 – $55.00

52W Low: $22.66 Position: 35.5% 52W High: $55.00

🔗 Compare Brokers

Key Metrics

P/E Ratio

853.75x

Price-to-Earnings

Forward P/E

16.36x

Forward Price/Earnings

P/S Ratio

1.31x

Price-to-Sales

EV/EBITDA

34.23x

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$1.6B

Market Capitalization

Revenue Growth

2.3%

YoY Revenue Growth

Profit Margin

0.17%

Net profit margin

ROE

0.17%

Return on Equity

Beta

0.86

Market sensitivity

Short Interest

8.9%

% of float sold short

Avg. Volume

659,062

Average daily volume

Valuation Analysis

Signal

Overvalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

7 analysts

Avg. Price Target

$57.43

+68.17% upside

Target Range

$49.00 – $70.00

About the Company

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medication dispensing; IV Compounding Service, an in-house compounding system; specialty pharmacy services, including turnkey solution to help health systems establish, manage, and optimize an entity-owned specialty pharmacy; EnlivenHealth platform to digitally enable retail and community pharmacies; medic

Sector: Healthcare Industry: Health Information Services Country: United States Employees: 3,580 Exchange: NMS